TABLE 2

Key pharmacokinetic parameters of eltrombopag after oral administration of eltrombopag olamine at 10 mg/kg to female mice without or with antibiotic treatment

Data are mean ± S.D., where applicable.

GroupTreatmentAUC0–taCmaxTmax
μg · h/mlμg/mlh
ANaive mice with eltrombopag93.9 ± 24.421.5 ± 4.31.01
BAntibiotic-treated mice with eltrombopag70.3 ± 11.819.3 ± 2.21.04
CVehicle-treated mice with eltrombopag109 ± 15.821.2 ± 5.81.02
  • a AUC0–t refers to the area from time 0 to the last quantifiable concentration.